ATE527371T1 - Expression löslicher, aktiver, eukaryotischer glucosyltransferasen in prokaryotischen organismen - Google Patents

Expression löslicher, aktiver, eukaryotischer glucosyltransferasen in prokaryotischen organismen

Info

Publication number
ATE527371T1
ATE527371T1 AT06748724T AT06748724T ATE527371T1 AT E527371 T1 ATE527371 T1 AT E527371T1 AT 06748724 T AT06748724 T AT 06748724T AT 06748724 T AT06748724 T AT 06748724T AT E527371 T1 ATE527371 T1 AT E527371T1
Authority
AT
Austria
Prior art keywords
active
soluble
eukaryotic
expression
prokaryotic organisms
Prior art date
Application number
AT06748724T
Other languages
English (en)
Inventor
Marc Schwartz
Tarik Soliman
Original Assignee
Biogenerix Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogenerix Ag filed Critical Biogenerix Ag
Application granted granted Critical
Publication of ATE527371T1 publication Critical patent/ATE527371T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT06748724T 2005-03-24 2006-03-24 Expression löslicher, aktiver, eukaryotischer glucosyltransferasen in prokaryotischen organismen ATE527371T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66539605P 2005-03-24 2005-03-24
US66889905P 2005-04-05 2005-04-05
US73240905P 2005-10-31 2005-10-31
PCT/US2006/011065 WO2006102652A2 (en) 2005-03-24 2006-03-24 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms

Publications (1)

Publication Number Publication Date
ATE527371T1 true ATE527371T1 (de) 2011-10-15

Family

ID=37024713

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06748724T ATE527371T1 (de) 2005-03-24 2006-03-24 Expression löslicher, aktiver, eukaryotischer glucosyltransferasen in prokaryotischen organismen

Country Status (10)

Country Link
US (3) US20100143969A1 (de)
EP (1) EP1863921B1 (de)
JP (1) JP5235657B2 (de)
KR (1) KR20080021590A (de)
AT (1) ATE527371T1 (de)
AU (1) AU2006226782B2 (de)
CA (1) CA2602329C (de)
ES (1) ES2374935T3 (de)
MX (1) MX2007011801A (de)
WO (1) WO2006102652A2 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002236234B2 (en) * 2001-03-06 2007-12-20 Phyton Holdings, LLC. Plant cell having animal-type sugar chain adding function
US7214660B2 (en) * 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
NZ542094A (en) 2003-03-14 2008-12-24 Neose Technologies Inc Branched polymer conjugates comprising a peptide and water-soluble polymer chains
PL1615945T3 (pl) 2003-04-09 2012-03-30 Ratiopharm Gmbh Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
NZ548123A (en) 2004-01-08 2010-05-28 Novo Nordisk As O-linked glycosylation of peptides
US20080300173A1 (en) * 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
WO2006031811A2 (en) 2004-09-10 2006-03-23 Neose Technologies, Inc. Glycopegylated interferon alpha
WO2006050247A2 (en) 2004-10-29 2006-05-11 Neose Technologies, Inc. Remodeling and glycopegylation of fibroblast growth factor (fgf)
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
US20100143969A1 (en) * 2005-03-24 2010-06-10 Neose Technologies, Inc. Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
WO2006121569A2 (en) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
EP2975135A1 (de) 2005-05-25 2016-01-20 Novo Nordisk A/S Glykopegylierter Faktor IX
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
US8198045B2 (en) * 2006-04-19 2012-06-12 Biogenerix Ag Expression of O-glycosylated therapeutic proteins in prokaryotic microorganisms
EP2049144B8 (de) 2006-07-21 2015-02-18 ratiopharm GmbH Glycosylierung von peptiden über o-verbundene glycosylierungssequenzen
EP2054521A4 (de) 2006-10-03 2012-12-19 Novo Nordisk As Verfahren zur reinigung von polypeptid-konjugate
AU2008227024A1 (en) * 2007-03-07 2008-09-18 Glycofi, Inc. Production of glycoproteins with modified fucosylation
HRP20130382T1 (hr) 2007-04-03 2013-05-31 Biogenerix Ag Postupci lijeäśenja pomoä†u glikopegiliranog g-csf
WO2008125972A2 (en) 2007-04-17 2008-10-23 Plant Research International B.V. Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
JP2008278761A (ja) * 2007-05-08 2008-11-20 Tokai Univ 新規β−ガラクトシドα２，６−シアル酸転移酵素
WO2008143944A2 (en) * 2007-05-14 2008-11-27 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Methods of glycosylation and bioconjugation
CA2690611C (en) 2007-06-12 2015-12-08 Novo Nordisk A/S Improved process for the production of nucleotide sugars
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
CN107119095B (zh) * 2008-01-03 2022-07-05 康乃尔研究基金会有限公司 原核生物中的糖基化蛋白表达
PL2257311T3 (pl) 2008-02-27 2014-09-30 Novo Nordisk As Koniugaty cząsteczek czynnika VIII
NO2501406T3 (de) 2009-11-19 2018-05-19
EP2536753B1 (de) 2010-02-16 2017-12-20 Novo Nordisk A/S Faktor-VIII-Moleküle mit reduzierter VWF-Bindung
JP2013519699A (ja) 2010-02-16 2013-05-30 ノヴォ ノルディスク アー／エス 因子ｖｉｉｉ融合タンパク質
JP5956982B2 (ja) 2010-05-27 2016-07-27 メルク・シャープ・エンド・ドーム・コーポレイション 改善された特性を有する抗体の製造方法
JP2013532176A (ja) 2010-07-15 2013-08-15 ノヴォ ノルディスク アー／エス 安定化させた第ｖｉｉｉ因子バリアント
EP2415779B1 (de) 2010-08-02 2015-01-21 ratiopharm GmbH Verfahren zur Herstellung und Reinigung einer aktiven löslichen Sialyltransferase
AU2012258907A1 (en) 2011-05-25 2013-11-07 Merck Sharp & Dohme Corp. Method for preparing Fc-containing polypeptides having improved properties
EP2852610B1 (de) 2012-05-23 2018-07-11 Glykos Finland Oy Herstellung von fucosylierten glykoproteinen
EP2877589B1 (de) 2012-07-26 2024-03-06 Momenta Pharmaceuticals, Inc. Glykoproteine mit entzündungshemmenden eigenschaften
SG11201508347YA (en) * 2013-03-14 2015-11-27 Glycobia Inc Oligosaccharide compositions, glycoproteins and methods to produce the same in prokaryotes
PL2991683T3 (pl) 2013-05-02 2020-03-31 Glykos Finland Oy Koniugaty glikoproteiny lub glikanu z toksycznym ładunkiem
CA2954534C (en) * 2014-07-07 2023-04-04 Targazyme, Inc. Manufacture and cryopreservation of fucosylated cells for therapeutic use
SG11201700446XA (en) 2014-07-21 2017-02-27 Glykos Finland Oy Production of glycoproteins with mammalian-like n-glycans in filamentous fungi
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2017117539A1 (en) 2015-12-30 2017-07-06 Northwestern University Cell-free glycoprotein synthesis (cfgps) in prokaryotic cell lysates enriched with components for glycosylation
US10829795B2 (en) 2016-07-14 2020-11-10 Northwestern University Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glycosylated proteins in prokaryotic cell lysates
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2019035916A1 (en) 2017-08-15 2019-02-21 Northwestern University DESIGN OF PROTEIN GLYCOSYLATION SITES BY RAPID EXPRESSION AND CHARACTERIZATION OF N-GLYCOSYLTRANSFERASES
US11530432B2 (en) 2018-03-19 2022-12-20 Northwestern University Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates
WO2019204346A1 (en) 2018-04-16 2019-10-24 Northwestern University METHODS FOR CO-ACTIVATING IN VITRO NON-STANDARD AMINO ACID (nsAA) INCORPORATION AND GLYCOSYLATION IN CRUDE CELLLYSATES
US12098433B2 (en) 2018-08-03 2024-09-24 Northwestern University On demand, portable, cell-free molecular sensing platform
CN113646438A (zh) 2019-01-11 2021-11-12 西北大学 在原核生物细胞裂解物中合成生物缀合物疫苗
US12325884B2 (en) 2019-03-04 2025-06-10 Northwestern University Riboswitch-based fluoride sensing in cell-free extract
US12226410B2 (en) 2019-10-18 2025-02-18 Northwestern University Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6
CN115135771A (zh) 2019-10-25 2022-09-30 西北大学 用于富集膜泡和增加糖蛋白产量的无细胞提取物制备方案
MX2022010467A (es) * 2020-02-25 2022-12-15 Momenta Pharmaceuticals Inc Enzimas para la sialilación de glicanos.
CA3174533A1 (en) * 2020-03-05 2021-09-10 Momenta Pharmaceuticals, Inc. Methods of making hyper-sialylated immunoglobulin
CN111534495B (zh) * 2020-05-14 2022-06-17 江南大学 一种提高重组n-乙酰葡糖胺转移酶ii可溶性表达的方法
WO2022207676A2 (en) 2021-03-29 2022-10-06 Imperial College Innovations Limited Methods and polynucleotides

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858751A (en) * 1992-03-09 1999-01-12 The Regents Of The University Of California Compositions and methods for producing sialyltransferases
GB9323225D0 (en) * 1993-11-10 1994-01-05 Unilever Plc Novel plant enzyme
US5639635A (en) 1994-11-03 1997-06-17 Genentech, Inc. Process for bacterial production of polypeptides
EP0786382A1 (de) 1996-01-26 1997-07-30 Morton International, Inc. Beifahrerseitiges Gaskissen
AU2660397A (en) 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
JP2001507215A (ja) 1997-01-16 2001-06-05 サイテル コーポレイション 組換え糖タンパク質のインビトロでの実用的なシアリル化
WO1998035049A1 (en) * 1997-02-07 1998-08-13 Oriental Yeast Co., Ltd. Recombinant yeast pdi and process for preparing the same
JP3344618B2 (ja) * 1997-06-20 2002-11-11 株式会社エイチ・エス・ピー研究所 シャペロン発現プラスミド
JPH11137247A (ja) 1997-11-10 1999-05-25 Toyobo Co Ltd β１，４−ガラクトース転移酵素の製造法
JPH11253163A (ja) 1998-03-11 1999-09-21 Toyobo Co Ltd シアル酸転移酵素の製造法
US6037730A (en) 1998-11-12 2000-03-14 Eaton Corporation Degraded electronic throttle operation method and system
US6949372B2 (en) 1999-03-02 2005-09-27 The Johns Hopkins University Engineering intracellular sialylation pathways
JP2001178453A (ja) 1999-12-24 2001-07-03 Toyobo Co Ltd Ｎ−アセチルグルコサミニルトランスフェラーゼの製造方法
US7338932B2 (en) * 2000-05-11 2008-03-04 Glycozym Aps Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
ES2411007T3 (es) * 2001-10-10 2013-07-04 Novo Nordisk A/S Remodelación y glicoconjugación de péptidos
US7179617B2 (en) 2001-10-10 2007-02-20 Neose Technologies, Inc. Factor IX: remolding and glycoconjugation of Factor IX
EP1477028A2 (de) * 2002-02-21 2004-11-17 BRITISH TELECOMMUNICATIONS public limited company Videoverarbeitung
EP1487966B1 (de) * 2002-03-23 2006-12-13 Research Development Foundation Sekretion von proteinen mit mehreren disulfidbindungen in bakterien und verwendungen davon
US7569376B2 (en) * 2002-05-03 2009-08-04 Neose Technologies, Inc. Fucosyltransferase fusion protein
JP2004016116A (ja) 2002-06-17 2004-01-22 Toyobo Co Ltd β１，４−Ｎ−アセチルガラクトサミニルトランスフェラーゼ活性を有する融合蛋白質及びその製造方法
JP2004016117A (ja) 2002-06-17 2004-01-22 Toyobo Co Ltd β１，３−ガラクトシルトランスフェラーゼ活性を有する融合蛋白質及びその製造方法
NZ543553A (en) * 2003-05-27 2008-12-24 Univ York Bioreactor containing cells expressing glycosyltransferase nucleic acids
JP2005046030A (ja) 2003-07-31 2005-02-24 Toyobo Co Ltd Ｉ分岐形成β１，６−Ｎ−アセチルグルコサミニルトランスフェラーゼ活性を有する融合タンパク質及びその製造方法
JP2005046031A (ja) 2003-07-31 2005-02-24 Toyobo Co Ltd α１，３−フコシルトランスフェラーゼＶＩ活性を有する融合タンパク質及びその製造方法
AU2005222782B2 (en) * 2004-02-04 2010-06-17 Ratiopharm Gmbh Methods of refolding mammalian glycosyltransferases
US20100143969A1 (en) 2005-03-24 2010-06-10 Neose Technologies, Inc. Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms

Also Published As

Publication number Publication date
CA2602329A1 (en) 2006-09-28
CA2602329C (en) 2016-08-09
MX2007011801A (es) 2008-02-19
US20060234345A1 (en) 2006-10-19
JP2008533992A (ja) 2008-08-28
AU2006226782B2 (en) 2011-12-08
EP1863921A4 (de) 2009-04-08
JP5235657B2 (ja) 2013-07-10
US20110223646A1 (en) 2011-09-15
ES2374935T3 (es) 2012-02-23
KR20080021590A (ko) 2008-03-07
US8137928B2 (en) 2012-03-20
US20100143969A1 (en) 2010-06-10
AU2006226782A1 (en) 2006-09-28
WO2006102652A2 (en) 2006-09-28
EP1863921B1 (de) 2011-10-05
WO2006102652A3 (en) 2007-05-24
EP1863921A2 (de) 2007-12-12

Similar Documents

Publication Publication Date Title
ATE527371T1 (de) Expression löslicher, aktiver, eukaryotischer glucosyltransferasen in prokaryotischen organismen
ATE518010T1 (de) Aktive oberflächengekoppelte polymerasen
TW200732349A (en) Anti-OX40L antibodies and methods using same
ATE424159T1 (de) Katheter
IL182403A0 (en) Systems and methods for ex-vivo organ care
AU307833S (en) Can insulator
WO2007053731A3 (en) Expression of soluble factor viii proteins in bacteria
MX2021015070A (es) Inmunomodulacion usando celulas madre de la placenta.
AU304952S (en) Toothbrush
MX2008008321A (es) Metodos para elaborar articulos polimericos y los articulos polimericos formados por este medio.
TW200739645A (en) Ion sources, systems and methods
DK1804589T3 (da) Fedtsammensætninger
IL190796A0 (en) Compositions and their uses for gene therapy of bone conditions
MX2009004883A (es) Piridil sulfoximinas multi-substituidas y su uso como insecticidas.
AU306306S (en) Toothbrush
WO2008066784A3 (en) Expression of foxp3 by cancer cells
AU307437S (en) Screwdriver
MX2009004030A (es) Articulos antimicrobianos y metodos de fabricacion.
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
AU306340S (en) Toothbrush
MX2007005202A (es) Polisacaridos de estreptococo modificados y usos de los mismos.
TW200732410A (en) Sprayable acoustic compositions
AU306157S (en) Toothbrush
AU305029S (en) Drill
SG129432A1 (en) Automated generation of multi-dimensional structure activity and structure property relationships

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties